Related Experiment Video
Updated: Jun 5, 2026

All-optical Mechanobiology Interrogation of Yes-associated Protein in Human Cancer and Normal Cells using a Multi-functional System
Published on: December 20, 2021
Angiomotin-like proteins associate with and negatively regulate YAP1
Wenqi Wang1, Jun Huang, Junjie Chen
1Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
Abstract:
In both Drosophila and mammalian systems, the Hippo pathway plays an important role in controlling organ size, mainly through its ability to regulate cell proliferation and apoptosis. The key component in the Hippo pathway is the Yes-associated protein YAP1, which localizes in nucleus, functions as a transcriptional coactivator, and regulates the expression of several proliferation- and apoptosis-related genes. The Hippo pathway negatively regulates YAP1 transcriptional activity by modulating its nuclear-cytoplasmic localization in a phosphorylation-dependent manner. Here, we describe the identification of several new PY motif-containing proteins, including angiomotin-like protein 1 (AMOTL1) and 2 (AMOTL2), as YAP1-associated proteins. We demonstrate that AMOTL1 and AMOTL2 can regulate YAP1 cytoplasm-to-nucleus translocation through direct protein-protein interaction, which can occur independent of YAP1 phosphorylation status. Moreover, down-regulation of AMOTL2 in MCF10A cells promotes epithelial-mesenchymal transition, a phenotype that is also observed in MCF10A cells with YAP1 overexpression. Together, these data support a new mechanism for YAP1 regulation, which is mediated via its direct interactions with angiomotin-like proteins.
Insights
New research reveals angiomotin-like proteins (AMOTL1 and AMOTL2) regulate the Yes-associated protein YAP1. These interactions control YAP1
Area of Science:
- Cell Biology
- Molecular Biology
- Genetics
Background:
- The Hippo pathway regulates organ size by controlling cell proliferation and apoptosis.
- Yes-associated protein YAP1 is a key transcriptional coactivator in this pathway.
- YAP1 activity is modulated by its nuclear-cytoplasmic localization, dependent on phosphorylation.
Purpose of the Study:
- To identify new YAP1-associated proteins.
- To elucidate novel mechanisms regulating YAP1.
- To investigate the role of angiomotin-like proteins in YAP1 function.
Main Methods:
- Co-immunoprecipitation to identify YAP1-binding proteins.
- Western blotting to assess protein interactions and localization.
- Cell culture experiments (MCF10A cells) to study phenotypic changes.
Main Results:
- Angiomotin-like protein 1 (AMOTL1) and angiomotin-like protein 2 (AMOTL2) were identified as YAP1-binding proteins.
- AMOTL1 and AMOTL2 directly interact with YAP1, regulating its translocation between the cytoplasm and nucleus.
- This regulation is independent of YAP1 phosphorylation.
- AMOTL2 downregulation in MCF10A cells induced epithelial-mesenchymal transition (EMT), similar to YAP1 overexpression.
Conclusions:
- A novel mechanism for YAP1 regulation involves direct interaction with AMOTL1 and AMOTL2.
- Angiomotin-like proteins modulate YAP1 activity and cellular processes like EMT.
- These findings provide new insights into Hippo pathway signaling and organ size control.
More Related Videos
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
10:32Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs
Published on: December 19, 2019
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Intracellular Signaling Affects Focal Adhesions
Some...
Microtubule Associated Proteins (MAPs)
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The JAK-STAT Signaling Pathway
Cytoskeletal Accessory Proteins